Navigation Links
Fair trade
Date:6/16/2008

This release is available in German.

Because of its toxicity and the dangers involved in handling it, tetrachloromethane (carbon tetrachloride, CCl4) can no longer be used or produced in many countries. However, the processes used in the production of other chlorinated hydrocarbons, such as chloroform (trichloromethane, CHCl3), also produce CCl4 as a byproduct. What is the best way to get rid of this unwanted substance? A team headed by Bert M. Weckhuysen at the University of Utrecht (Netherlands) has now found an interesting new approach that may lead to effective recycling. As the researchers report in the journal Angewandte Chemie, a lanthanum chloride catalyst induces CCl4 and its reaction partner dichloromethane (CH2Cl2) to exchange one chlorine atom for a hydrogen atom, forming nearly 100 % of the desired CHCl3.

In order to increase the catalyst surface, lanthanum chloride (LaCl3) was deposited onto carbon nanofiber supports. This results in a highly active, selective, and stable catalyst to facilitate the hydrogenchlorine exchange between CCl4 and CH2Cl2. "Computer calculations suggest," says Weckhuysen, "that the mechanism occurs by way of two separate hydrogenchlorine exchange reactions." It appears that the surface of the LaCl3 catalyst contains not only the terminal chlorine atoms of the crystal lattice, but also other weakly adsorbed species. CH2Cl2 swaps one of its hydrogen atoms for one such weakly bound chlorine atom. It leaves behind the hydrogen atom, which is in turn weakly adsorbed to the catalyst surface. This hydrogen atom can be taken up by CCl4, which in turn leaves one of its chlorine atoms behind on the catalyst surface. Both of these reaction steps produce chloroform exclusively; no byproducts come into play.

This new catalytic reaction is astonishing in that it was previously assumed that the presence of oxygeneither in the gas phase or bound to the crystal lattice of the catalystis required for such reactions. Says Weckhuysen: "We are reporting for the first time a lanthanum-based catalyst material that can activate both C-H and C-Cl bonds in the absence of oxygen." (2193 characters)


'/>"/>

Contact: Bert M. Weckhuysen
b.m.weckhuysen@uu.nl
31-302-534-328
Wiley-Blackwell
Source:Eurekalert  

Related biology news :

1. Stinger Systems To Offer Taser Trade-In Program
2. Global trade in tiger shrimp threatens environment
3. Markets of biodiversity and equity in trade: An illusion?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fair trade
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s Medical ... place on 7th and 8th June 2018 in San Francisco, CA. The Summit brings ... well as several distinguished CEOs, board directors and government officials from around the world ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the ... for Excellence in Volunteer Experience from US2020. , US2020’s mission is to change ...
Breaking Biology Technology: